PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy

Pharmacological suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers

(2020) Xinxin Song et al.   Cancer Discovery

Glycoproteomic identification of novel plasma biomarkers for oral cancer

(2019) Shu-Chieh Chang et al.   JOURNAL OF FOOD AND DRUG ANALYSIS

Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

(2019) Heng-Huan Lee et al.   CANCER CELL

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

(2019) Li-Chuan Chan et al.   JOURNAL OF CLINICAL INVESTIGATION

Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial

(2019) Joris B.W. Elbers et al.   RADIOTHERAPY AND ONCOLOGY

Mechanistic reconstruction of glycoprotein secretion through monitoring of intracellular N-glycan processing

(2019) Ilaria Arigoni-Affolter et al.   Science Advances

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

(2018) Chia-Wei Li et al.   CANCER CELL

STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner

(2018) Shanshan Sun et al.   CLINICAL CANCER RESEARCH

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

(2018) Daniel E. Johnson et al.   Nature Reviews Clinical Oncology

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

(2018) Jong-Ho Cha et al.   MOLECULAR CELL

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

(2017) Jiehui Deng et al.   Cancer Discovery

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients

(2017) et al.   Cancers

N-linked glycan stabilization of the VWF A2 domain

(2016) C. J. Lynch et al.   BLOOD

Deubiquitination and Stabilization of PD-L1 by CSN5

(2016) Seung-Oe Lim et al.   CANCER CELL

Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease

(2016) Hironobu Fujii et al.   GASTROENTEROLOGY

Fluorogenic probes reveal a role of GLUT4 N-glycosylation in intracellular trafficking

(2016) Shinya Hirayama et al.   Nature Chemical Biology

The "cancer immunogram"

(2016) C. U. Blank et al.   SCIENCE

α integrin targeting for radiosensitization of three-dimensionally grown human head and neck squamous cell carcinoma cells

(2015) Anne Steglich et al.   CANCER LETTERS

Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer

(2015) Iris Eke et al.   JNCI-Journal of the National Cancer Institute

The genomic landscape of response to EGFR blockade in colorectal cancer

(2015) Andrea Bertotti et al.   NATURE

Glycosylation-directed quality control of protein folding

(2015) Chengchao Xu et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer

(2015) Iris Eke et al.   JNCI-Journal of the National Cancer Institute

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients

(2015) Jing Li et al.   Journal for ImmunoTherapy of Cancer

Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance

(2014) Camilla Jandus et al.   JOURNAL OF CLINICAL INVESTIGATION

Identification of novel tumor markers for oral squamous cell carcinoma using glycoproteomic analysis

(2012) Yi-Ting Chen et al.   CLINICA CHIMICA ACTA

The PD-1 pathway in tolerance and autoimmunity

(2010) Loise M. Francisco et al.   IMMUNOLOGICAL REVIEWS